Bagley Summarizes the ACTION trial of ONC201 in H3 K27M–Mutant Diffuse Midline Gliomas

Welcome to OncLive On Air^®! I’m your host today, Caroline Seymour.

OncLive On Air is a podcast from OncLive^®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, sponsored by Chimerix, we had the pleasure of speaking with Stephen Bagley, MD, MSCE, an assistant professor of medicine in hematology-oncology at the Hospital of the University of Pennsylvania, as well as section chief in Neuro-Oncology and an assistant professor of medicine in neurosurgery at Penn Medicine in Philadelphia.

In our exclusive interview, Dr Bagley discussed the evaluation of the small molecule ONC201 in the phase 3 ACTION trial (NCT05580562) in patients with H3 K27M–mutant diffuse midline gliomas and explained why clinicians should consider the trial for their patients.

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air, sponsored by Chimerix. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air.

*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.